All News #Library
Biotech
Barinthus Bio Unveils Q1 2026 Financials And Corporate Progress
30 Apr 2026 //
GLOBENEWSWIRE
Barinthus Bio Updates Phase 1 Celiac Trial of VTP-1000
10 Dec 2025 //
GLOBENEWSWIRE
Barinthus Bio Updates on Corporate Developments, Q2 2025
07 Aug 2025 //
GLOBENEWSWIRE
Barinthus Biotherapeutics to Present at Investor Summit Virtual
12 Mar 2025 //
BIOSPACE
Barinthus Focuses On Immunology & Provides Financial Update
10 Jan 2025 //
GLOBENEWSWIRE
Arbutus & Barinthus Report Nivolumab raise HBsAg Loss in Hepatitis B
15 Nov 2024 //
GLOBENEWSWIRE
Barinthus Bio to Present at AASLD 2024 & Attend Nov Conferences
31 Oct 2024 //
GLOBENEWSWIRE
Barinthus Bio Completes Enrollment in Chronic Hepatitis B Trial
01 Oct 2024 //
GLOBENEWSWIRE
Barinthus Bio`s VTP-300 Trials Show Undetectable HBsAg And HBsAg Lowering
06 Jun 2024 //
GLOBENEWSWIRE
Barinthus Bio Reports Topline Phase 1b/2 VTP-200 HPV Infection Data
18 Apr 2024 //
GLOBENEWSWIRE
New partnership aims to advance vaccine against MERS coronavirus
21 Dec 2023 //
GLOBENEWSWIRE
Barinthus` gets $35M booster from CEPI to develop MERS shot
21 Dec 2023 //
FIERCE BIOTECH

Market Place
Sourcing Support